Literature DB >> 7188336

Quantitative evaluation of sympathetic and parasympathetic control of iris function.

M A Pfeifer, D Cook, J Brodsky, D Tice, D Parrish, A Reenan, J B Halter, D Porte.   

Abstract

The use of quantitative measurements of pupil size as an index of autonomic nervous system (ANS) activity in normal and diabetic subjects is described. The dual innervation of the iris by the parasympathetic (PNS) and sympathetic (SNS) nervous system was demonstrated by measurement of steady-state pupil size before and after changes in ANS activity by pharmacologic agents. In the presence of total PNS blockade, dark-adapted pupil size was a reliable index of SNS activity to the iris. Latency time (time from light stimulation to initial pupil response) appeared to be a good index of PNS activity. However, increased SNS activity may also prolong the latency time. Thus, consideration of SNS activity is necessary when evaluating the latency time. In 25 diabetic subjects, there was evidence of impaired SNS activity (smaller dark-adapted pupil size during total PNS blockade) and PNS activity (prolonged latency time). In a subgroup of diabetic subjects without clinical manifestations of autonomic neuropathy and normal subjects, both dark-adapted pupil size during PNS blockade (SNS index) and latency time (PNS index) were abnormal. The coefficient of variation for these two indices was less than 5% in glycemic stable diabetic subjects. Thus, these two indices are reliable and sensitive measures of the SNS and PNS activity to the iris in normal and diabetic subjects.

Entities:  

Mesh:

Year:  1982        PMID: 7188336     DOI: 10.2337/diacare.5.5.518

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  12 in total

1.  Subclinical diabetic neuropathy: similarities between electrophysiological results of patients with type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P H Hendriksen; P L Oey; G H Wieneke; B Bravenboer; J D Banga
Journal:  Diabetologia       Date:  1992-07       Impact factor: 10.122

2.  Assessment of pupillary light reflex latency and darkness adapted pupil size in control subjects and in diabetic patients with and without cardiovascular autonomic neuropathy.

Authors:  P Lanting; J E Bos; J Aartsen; L Schuman; J Reichert-Thoen; J J Heimans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-10       Impact factor: 10.154

3.  Detection of the pupil constriction latency.

Authors:  J E Bos
Journal:  Med Biol Eng Comput       Date:  1991-09       Impact factor: 2.602

4.  Attenuation of the pupillary light reflex in anxious patients.

Authors:  A Bakes; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

5.  Immediate effects of a thoracic spine thrust manipulation on the autonomic nervous system: a randomized clinical trial.

Authors:  Rob Sillevis; Joshua Cleland; Madeleine Hellman; Kristina Beekhuizen
Journal:  J Man Manip Ther       Date:  2010-12

6.  Pupillary autonomic denervation with increasing duration of diabetes mellitus.

Authors:  M Cahill; P Eustace; V de Jesus
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

7.  Pupillary light reflex and quantitative sensory and motor neural function tests in diabetic patients.

Authors:  P Lanting; J J Heimans; J P Reulen; J Nauta; E A van der Veen
Journal:  J Neurol       Date:  1988-03       Impact factor: 4.849

8.  The pupillary response to light in type 1 (insulin-dependent) diabetes.

Authors:  A B Hreidarsson; H J Gundersen
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

9.  Pupillary responses to single and sinusoidal light stimuli in diabetic patients.

Authors:  Wolfgang H Zangemeister; Thilo Gronow; Ulrich Grzyska
Journal:  Neurol Int       Date:  2009-11-16

10.  Parasympathetic Nervous System Dysfunction, as Identified by Pupil Light Reflex, and Its Possible Connection to Hearing Impairment.

Authors:  Yang Wang; Adriana A Zekveld; Graham Naylor; Barbara Ohlenforst; Elise P Jansma; Artur Lorens; Thomas Lunner; Sophia E Kramer
Journal:  PLoS One       Date:  2016-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.